2021
DOI: 10.1007/s13311-021-01043-4
|View full text |Cite
|
Sign up to set email alerts
|

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice

Abstract: Depletion of the enzyme cofactor, tetrahydrobiopterin (BH4), in T-cells was shown to prevent their proliferation upon receptor stimulation in models of allergic inflammation in mice, suggesting that BH4 drives autoimmunity. Hence, the clinically available BH4 drug (sapropterin) might increase the risk of autoimmune diseases. The present study assessed the implications for multiple sclerosis (MS) as an exemplary CNS autoimmune disease. Plasma levels of biopterin were persistently low in MS patients and tended t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 88 publications
1
3
0
Order By: Relevance
“…Additionally, the content of biopterin in LN patients' serum exhibited a marked decrease. Other studies reported similar findings in patients with SLE, rheumatoid arthritis (RA), and multiple sclerosis (MS), associating this abnormal change with excessive autoimmune responses 19 , 20 . However, the specific mechanism remains unclear.…”
Section: Discussionsupporting
confidence: 52%
“…Additionally, the content of biopterin in LN patients' serum exhibited a marked decrease. Other studies reported similar findings in patients with SLE, rheumatoid arthritis (RA), and multiple sclerosis (MS), associating this abnormal change with excessive autoimmune responses 19 , 20 . However, the specific mechanism remains unclear.…”
Section: Discussionsupporting
confidence: 52%
“…Of interest, recent work demonstrated elevated mRNA levels of CerS3 and 6 in brain endothelial cells of evoked autoimmune encephalomyelitis mice, suggesting their implication in the rising levels of Cer related to endothelial dysfunction ( Schmitz et al, 2021 ).…”
Section: Stroke and Ceramide Metabolismmentioning
confidence: 99%
“…BH4 availability has been shown to act as a rate-limiting factor for T cell proliferation and activity in diverse models of immunity, including within solid tumors ( 20 , 64 ). This acceleration in T cell proliferation may occur due to increased iron-redox recycling of T cell mitochondrial cytochrome c which otherwise results in defective oxidative phosphorylation and superoxide production upon TCR stimulation ( 20 , 35 ).…”
Section: Bh4 Metabolism In Tumorigenesismentioning
confidence: 99%